Normal Nicotine Content Cigarettes
Normal Nicotine Content Cigarettes is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco
Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2
Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers
Clinical Trials (6)
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco
Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2
Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers
Very-Low Nicotine Cigarettes and Non-Daily Smokers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6